Logo image of AKAST.OL

AKASTOR ASA (AKAST.OL) Stock Fundamental Analysis

Europe - OSL:AKAST - NO0010215684 - Common Stock

11.17 NOK
-0.05 (-0.45%)
Last: 10/21/2025, 2:09:00 PM
Fundamental Rating

2

Taking everything into account, AKAST scores 2 out of 10 in our fundamental rating. AKAST was compared to 35 industry peers in the Energy Equipment & Services industry. While AKAST seems to be doing ok healthwise, there are quite some concerns on its profitability. AKAST does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AKAST had negative earnings in the past year.
AKAST had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AKAST reported negative net income in multiple years.
In multiple years AKAST reported negative operating cash flow during the last 5 years.
AKAST.OL Yearly Net Income VS EBIT VS OCF VS FCFAKAST.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

With a Return On Assets value of -0.93%, AKAST is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -1.06%, AKAST is doing worse than 74.29% of the companies in the same industry.
The Return On Invested Capital of AKAST (0.25%) is worse than 82.86% of its industry peers.
Industry RankSector Rank
ROA -0.93%
ROE -1.06%
ROIC 0.25%
ROA(3y)5.41%
ROA(5y)4.53%
ROE(3y)4.92%
ROE(5y)4.27%
ROIC(3y)N/A
ROIC(5y)N/A
AKAST.OL Yearly ROA, ROE, ROICAKAST.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

AKAST's Profit Margin has improved in the last couple of years.
The Operating Margin of AKAST (5.52%) is worse than 77.14% of its industry peers.
AKAST has a Gross Margin (27.91%) which is comparable to the rest of the industry.
AKAST's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.52%
PM (TTM) N/A
GM 27.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y77.83%
PM growth 5Y213.61%
GM growth 3Y-21.44%
GM growth 5Y-8.67%
AKAST.OL Yearly Profit, Operating, Gross MarginsAKAST.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AKAST is destroying value.
Compared to 1 year ago, AKAST has about the same amount of shares outstanding.
AKAST has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AKAST has an improved debt to assets ratio.
AKAST.OL Yearly Shares OutstandingAKAST.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
AKAST.OL Yearly Total Debt VS Total AssetsAKAST.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

A Debt/Equity ratio of 0.04 indicates that AKAST is not too dependend on debt financing.
The Debt to Equity ratio of AKAST (0.04) is better than 88.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.02
WACC10.44%
AKAST.OL Yearly LT Debt VS Equity VS FCFAKAST.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.19 indicates that AKAST has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.19, AKAST is doing good in the industry, outperforming 74.29% of the companies in the same industry.
AKAST has a Quick Ratio of 2.19. This indicates that AKAST is financially healthy and has no problem in meeting its short term obligations.
AKAST has a better Quick ratio (2.19) than 77.14% of its industry peers.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 2.19
AKAST.OL Yearly Current Assets VS Current LiabilitesAKAST.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

1

3. Growth

3.1 Past

AKAST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -104.78%.
Measured over the past years, AKAST shows a very strong growth in Earnings Per Share. The EPS has been growing by 75.95% on average per year.
The Revenue for AKAST has decreased by -61.04% in the past year. This is quite bad
AKAST shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -44.12% yearly.
EPS 1Y (TTM)-104.78%
EPS 3Y21.55%
EPS 5Y75.95%
EPS Q2Q%-102.33%
Revenue 1Y (TTM)-61.04%
Revenue growth 3Y-31.61%
Revenue growth 5Y-44.12%
Sales Q2Q%-13.19%

3.2 Future

AKAST is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -38.02% yearly.
Based on estimates for the next years, AKAST will show a very negative growth in Revenue. The Revenue will decrease by -22.85% on average per year.
EPS Next Y-90.48%
EPS Next 2Y-51.2%
EPS Next 3Y-38.02%
EPS Next 5YN/A
Revenue Next Year-58.39%
Revenue Next 2Y-32.24%
Revenue Next 3Y-22.85%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AKAST.OL Yearly Revenue VS EstimatesAKAST.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B
AKAST.OL Yearly EPS VS EstimatesAKAST.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AKAST. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 21.69, the valuation of AKAST can be described as rather expensive.
Based on the Price/Forward Earnings ratio, AKAST is valued expensively inside the industry as 80.00% of the companies are valued cheaper.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, AKAST is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 21.69
AKAST.OL Price Earnings VS Forward Price EarningsAKAST.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKAST is valued expensively inside the industry as 80.00% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 45.94
AKAST.OL Per share dataAKAST.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as AKAST's earnings are expected to decrease with -38.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.2%
EPS Next 3Y-38.02%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AKAST!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AKASTOR ASA

OSL:AKAST (10/21/2025, 2:09:00 PM)

11.17

-0.05 (-0.45%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)07-10 2025-07-10
Earnings (Next)10-30 2025-10-30
Inst Owners17.33%
Inst Owner ChangeN/A
Ins Owners1.64%
Ins Owner ChangeN/A
Market Cap3.06B
Analysts86
Price Target20.4 (82.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.61%
Min Revenue beat(2)-13.82%
Max Revenue beat(2)-5.4%
Revenue beat(4)2
Avg Revenue beat(4)-2.08%
Min Revenue beat(4)-13.82%
Max Revenue beat(4)10.48%
Revenue beat(8)4
Avg Revenue beat(8)-3.02%
Revenue beat(12)5
Avg Revenue beat(12)-15.39%
Revenue beat(16)9
Avg Revenue beat(16)-8.29%
PT rev (1m)0%
PT rev (3m)-4.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.69
P/S 8.9
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB 0.56
EV/EBITDA 45.94
EPS(TTM)-0.22
EYN/A
EPS(NY)0.52
Fwd EY4.61%
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS1.26
BVpS19.95
TBVpS19.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.93%
ROE -1.06%
ROCE 0.32%
ROIC 0.25%
ROICexc 0.26%
ROICexgc 0.26%
OM 5.52%
PM (TTM) N/A
GM 27.91%
FCFM N/A
ROA(3y)5.41%
ROA(5y)4.53%
ROE(3y)4.92%
ROE(5y)4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y77.83%
PM growth 5Y213.61%
GM growth 3Y-21.44%
GM growth 5Y-8.67%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 3.95
Cap/Depr 92.5%
Cap/Sales 10.76%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.19
Quick Ratio 2.19
Altman-Z N/A
F-Score4
WACC10.44%
ROIC/WACC0.02
Cap/Depr(3y)202.64%
Cap/Depr(5y)136.86%
Cap/Sales(3y)20%
Cap/Sales(5y)16.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-104.78%
EPS 3Y21.55%
EPS 5Y75.95%
EPS Q2Q%-102.33%
EPS Next Y-90.48%
EPS Next 2Y-51.2%
EPS Next 3Y-38.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-61.04%
Revenue growth 3Y-31.61%
Revenue growth 5Y-44.12%
Sales Q2Q%-13.19%
Revenue Next Year-58.39%
Revenue Next 2Y-32.24%
Revenue Next 3Y-22.85%
Revenue Next 5YN/A
EBIT growth 1Y-96.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-92.76%
EBIT Next 3Y-54.03%
EBIT Next 5YN/A
FCF growth 1Y59.87%
FCF growth 3YN/A
FCF growth 5Y42.34%
OCF growth 1Y83.89%
OCF growth 3YN/A
OCF growth 5Y34.38%